| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/22/2002 | EP1206448A1 Novel vitamin d analogues |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206442A1 Substituted chiral allosteric hemoglobin modifiers |
| 05/22/2002 | EP1206268A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 05/22/2002 | EP1206262A1 Npy antagonists: spiroisoquinolinone derivatives |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
| 05/22/2002 | EP1109558B1 Sustained release ranolazine formulations |
| 05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 05/22/2002 | EP0902681B1 Inhibition of selectin binding |
| 05/22/2002 | EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof |
| 05/22/2002 | EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 05/22/2002 | EP0583360B1 Compositions for the prevention and/or treatment of pathological processes |
| 05/22/2002 | EP0563238B1 Imidazolyl-alkenoic acids |
| 05/22/2002 | CN1350583A Recombinant platelet collagen receptor Glycoprotein VI and its pharmaceutical use |
| 05/22/2002 | CN1350545A Spray drying of thrombin inhibitors |
| 05/22/2002 | CN1350539A Imidazo-containing heterocyclic compounds, their compositions and uses |
| 05/22/2002 | CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative |
| 05/22/2002 | CN1350534A Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 05/22/2002 | CN1350533A New ECE inhibitors, their production and their use |
| 05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
| 05/22/2002 | CN1350528A 4,5,6,7-tetrahydroindazole derivatives as antitumor agents |
| 05/22/2002 | CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use |
| 05/22/2002 | CN1350466A A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes |
| 05/22/2002 | CN1350463A A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 05/22/2002 | CN1349983A Non-peptide neomatal vascularization inhibitor |
| 05/22/2002 | CN1349819A Myocarditis treating Chinese medicine prepn |
| 05/22/2002 | CN1349818A Effective part group in red sage mixture and its delayed release prepn. medicinal use and prepn process |
| 05/22/2002 | CN1349816A Medicine for treating Alzheimer disease and cerebral ischemic encephalopathy and its prepn |
| 05/22/2002 | CN1349814A Composite Chinese medicine for treaitng coronary heart disease |
| 05/22/2002 | CN1349803A Medicine for treating diabetes and coronary heart disease |
| 05/22/2002 | CN1085212C Rapamycin 42-oximes and hydroxylamines |
| 05/22/2002 | CN1085208C Process for preparing eprosartan |
| 05/22/2002 | CN1085205C Bicyclic amino acids |
| 05/22/2002 | CN1085083C Medicine for curing stenocardia-type coronary heart disease and producing method thereof |
| 05/22/2002 | CN1085082C Medicine for curing arrhythmic coronary heart disease and producing method thereof |
| 05/22/2002 | CN1085081C Compound fish oil |
| 05/21/2002 | US6392053 Process for preparing arylacetylaminothiazoles |
| 05/21/2002 | US6392039 Coupling; salt formation |
| 05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
| 05/21/2002 | US6391904 Bone disorders |
| 05/21/2002 | US6391894 Myt1 kinase inhibitors |
| 05/21/2002 | US6391892 Naphthyl pharmaceutical compounds |
| 05/21/2002 | US6391891 Bicyclic compounds as ligands for 5-HT1 receptors |
| 05/21/2002 | US6391888 Topical anesthetics useful for treating cancer |
| 05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
| 05/21/2002 | US6391880 Anticholesterol agents |
| 05/21/2002 | US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 05/21/2002 | US6391872 Indazole bioisostere replacement of catechol in therapeutically active compounds |
| 05/21/2002 | US6391832 Medical emulsion for lubrication and delivery of drugs |
| 05/21/2002 | US6391616 Oidiodendron strain for the production of terpenoid lactone compounds |
| 05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
| 05/21/2002 | CA2268327C 3-carboxamide derivatives of 5h-pyrrolo[2,1-c][1,4]-benzodiazepines |
| 05/21/2002 | CA2223245C Catechol diethers derivatives useful as pharmaceutical agents |
| 05/21/2002 | CA2183241C Yeast strains and modified albumins |
| 05/21/2002 | CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same |
| 05/16/2002 | WO2002038794A2 Cardiovascular disease diagnostic and therapeutic targets |
| 05/16/2002 | WO2002038781A1 Use of heart-specific transcription factors of the basic helix-loop-helix type for treating cardiac power failure |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038726A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/16/2002 | WO2002038609A2 Apolipoprotein conjugates |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 05/16/2002 | WO2002038571A1 Novel compounds |
| 05/16/2002 | WO2002038570A1 Novel compounds |
| 05/16/2002 | WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038557A2 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
| 05/16/2002 | WO2002038553A2 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
| 05/16/2002 | WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002038186A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/16/2002 | WO2002038184A1 Oral pharmaceutical composition containing a block copolymer |
| 05/16/2002 | WO2002038169A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | WO2002038165A1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
| 05/16/2002 | WO2002038158A1 Improved treatment |
| 05/16/2002 | WO2002038157A2 Inhibitors of thromboxane formation and action |
| 05/16/2002 | WO2002038153A1 New use of 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine derivatives |
| 05/16/2002 | WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | WO2002038129A2 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 05/16/2002 | WO2002038108A2 Methods of treating disorders related to apoe |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002020488A3 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 05/16/2002 | WO2002020003A3 Use of carp inhibitors for the treatment of heart diseases |
| 05/16/2002 | WO2002017892A3 Water-dispersible encapsulated sterols |
| 05/16/2002 | WO2002012539A3 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2002000680A3 Cationic steroid derivatives for gene delivery |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001088533A3 Lipid uptake assays |
| 05/16/2002 | WO2001087038A3 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001083552A3 Human sez6 nucleic acids and polypeptides |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081622A8 Diagnosis of diseases associated with dna repair |